Aspirin therapy after heart transplantation is associated with higher myocardial perfusion reserve assessed by cardiovascular magnetic resonance imaging
BACKGROUNDCardiac allograft vasculopathy (CAV) is one of the major long-term complications in patients after heart transplantation (HTx) limiting allograft function and longevity.CAV can be studied J o u r n a l P r e -p r o o f CONCLUSIONIn this retrospective study, aspirin therapy in heart transplant patients was independently associated with higher myocardial perfusion reserve.
Authors
- R. Jablonowski
- H. Arheden
- G. Gjesdal
- I Haugen Lofman
- M Carlsson
- O. Braun
- H.B. Andersson
- M. Melin
- J. Nickander
- H. Engblom
- P. Kellman
- C. Fogarasi
Institutions
- National Institutes of Health (US)
- Karolinska University Hospital (SE)
- Lund University (SE)
- Karolinska Institutet (SE)
- National Heart, Lung, and Blood Institute (US)
- Karolinska Development (Sweden) (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- JHLT Open
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1016/j.jhlto.2026.100592
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hjärt-Lungfonden